St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on April 29, 2026

Apr. 29, 2026

U.S. News & World Report Announces "Best of" 2026 Ratings for Legend Senior Living® Residences

Indeterminate GlobeNewswire

Apr. 29, 2026

The American Case Management Association and Xsolis Announce 2026 Case Management Hero Award Honorees

Indeterminate GlobeNewswire

Apr. 29, 2026

Global Wound Care Market to Reach USD 30.48 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire

Apr. 29, 2026

Stopping the ‘Silent Killer:’ How to Check, Prevent and Manage High Blood Pressure

Indeterminate GlobeNewswire

Apr. 29, 2026

Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference

Indeterminate GlobeNewswire

Apr. 29, 2026

SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire

Apr. 29, 2026

Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)

Indeterminate GlobeNewswire

Apr. 29, 2026

Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD

Indeterminate GlobeNewswire

Apr. 29, 2026

Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045

Indeterminate GlobeNewswire

Apr. 29, 2026

Dr. Carsten Engel Joins Joint Commission as International Strategic Advisor

Indeterminate GlobeNewswire

Apr. 29, 2026

Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 29, 2026

Codexis to share RNA manufacturing advances at TIDES USA

Indeterminate GlobeNewswire

Apr. 29, 2026

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

Indeterminate GlobeNewswire

Apr. 29, 2026

Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

Indeterminate GlobeNewswire

Apr. 29, 2026

RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET

Indeterminate GlobeNewswire

Apr. 29, 2026

Imviva Biotech to Present Clinical Data from Ongoing Phase 1/2 Study of CTA313 at the American Society of Gene & Cell Therapy's Annual Meeting

Indeterminate GlobeNewswire

Apr. 29, 2026

Inaugural Laudio-ASHHRA Report Reveals How HR Leaders Can Strengthen Workforce Stability Through Frontline Leadership

Indeterminate GlobeNewswire

Apr. 29, 2026

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 29, 2026

TOMI Environmental Solutions Targets $70 Billion U.S. Drone and Defense Budget with Autonomous SteraMist iHP Decontamination

Indeterminate GlobeNewswire

Apr. 29, 2026

Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias

Indeterminate GlobeNewswire